Related Experiment Video
Updated: Feb 14, 2026

Dual-color Correlative Light and Electron Microscopy for the Visualization of Interactions between Mitochondria and Lysosomes
Published on: September 27, 2024
Dual targeting of oncogenic microtubules and mitochondria in PDAC
Michael W Spinrad1, Chun Cai1,2, Lauren C Gattie1
1Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Microtubule inhibition is a promising therapeutic target as microtubule dynamics play a critical role in growth of metastases due to over expression of several β-tubulin subtypes compared to normal cells. Previous studies have shown that decreased expression of βIII- and βIVb-tubulin is associated with decreased PDAC cell growth. Bromodomain and Extra-Terminal domain (BET) proteins are transcription factors that regulate mitochondria proteins. In this study, we hypothesize that SB-216 and Veru-111 (related novel compounds) inhibit cell growth via suppression of oncogenic βIII- and βIVb-tubulin subtypes and mitochondria function via suppression of BRD4, the most active BET protein. PDAC cell growth was analyzed with the IncuCyte Live-Cell Analysis system. mRNA expression of βIII- and βIVb-tubulin was evaluated with quantitative real time PCR. Western blot analysis was performed for βIII, βIVb-tubulin, and BRD4 protein expression and expression of autophagy and mitophagy markers LC3B and p62/SQSTM1. Mitochondrial function/respiration was measured using a Seahorse XF-24 Flux Analyzer. Cell growth was greatly inhibited across all doses in multiple PDAC cell lines (p < .0001). mRNA expression of TUBB3 (βIII subtype) and TUBB4 (βIVb subtype) was significantly decreased (p < .05). BRD4 protein expression was reduced in with compensatory increase in mRNA expression. Treated PDCL had reduced mitochondrial respiration. Autophagy markers were increased in treated PDAC cells. Our data demonstrates that SB-216 effectively inhibits PDAC cell growth through inhibiting oncogenic microtubules and mitochondrial function. This novel approach simultaneously targets two hallmarks of cancer and patient demise.
Insights
SB-216 significantly inhibits pancreatic cancer cell growth by targeting oncogenic microtubules and mitochondrial function. This dual approach suppresses key cancer drivers, offering a novel therapeutic strategy for pancreatic ductal adenocarcinoma (PDAC).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with limited treatment options.
- Microtubule dynamics, particularly βIII- and βIVb-tubulin overexpression, are implicated in PDAC growth and metastasis.
- Bromodomain and Extra-Terminal domain (BET) proteins, like BRD4, regulate mitochondrial function and are potential therapeutic targets.
Purpose of the Study:
- To investigate the efficacy of SB-216 and Veru-111 in inhibiting PDAC cell growth.
- To determine if these compounds suppress oncogenic βIII- and βIVb-tubulin subtypes and mitochondrial function via BRD4 inhibition.
- To explore the simultaneous targeting of microtubule dynamics and mitochondrial respiration in PDAC.
Main Methods:
- Cell growth was assessed using the IncuCyte Live-Cell Analysis system.
- Quantitative real-time PCR and Western blot analysis were used to evaluate mRNA and protein expression of βIII-tubulin, βIVb-tubulin, and BRD4.
- Mitochondrial respiration was measured with a Seahorse XF-24 Flux Analyzer, and autophagy/mitophagy markers were analyzed.
Main Results:
- SB-216 and Veru-111 significantly inhibited PDAC cell growth across multiple cell lines and doses (p < .0001).
- Treatment led to decreased mRNA expression of TUBB3 (βIII) and TUBB4 (βIVb) and reduced BRD4 protein levels.
- Mitochondrial respiration was impaired, and autophagy markers increased in treated PDAC cells.
Conclusions:
- SB-216 effectively inhibits PDAC cell growth by targeting both oncogenic microtubules and mitochondrial function.
- This novel therapeutic strategy simultaneously targets two critical hallmarks of cancer progression and lethality.
- The findings support the development of BET inhibitors like SB-216 for pancreatic cancer treatment.
More Related Videos
07:21Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues
Published on: November 17, 2023
13:42Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria
Published on: September 7, 2012
Related Concept Videos
Microtubules
Microtubules
Microtubules have two structurally similar globular protein subunits: α and β tubulins. In the cytosol, the α and β tubulins form a heterodimer....
Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
Mitochondria
Microtubule Instability
Microtubule Formation